Alto Neuroscience

Clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

HQ location

Los Altos, United States

Website

altoneuroscience.com

Launch date

2019

Employees

Market cap

Enterprise value

($72m)

Share price

$2.20 ANRO

https://twitter.com/altoneuro https://www.linkedin.com/company/altoneuroscience/

Authorizing premium user...